电解还原水透析液可改善慢性血液透析终末期肾病患者的 T 细胞损伤。
Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.
机构信息
Department of Family Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan.
出版信息
Nephrol Dial Transplant. 2010 Aug;25(8):2730-7. doi: 10.1093/ndt/gfq082. Epub 2010 Feb 26.
BACKGROUND
T-cell damage by increased oxidative stress in end-stage renal disease (ESRD) patients undergoing chronic haemodialysis (HD) led to the increased T-cell apoptosis and the alteration of surface markers and Th1/Th2 ratio in CD4(+) T lymphocytes. Antioxidant electrolysed-reduced water (ERW) was used as the dialysate in ESRD patients undergoing chronic HD to test for improved oxidative stress-related T-cell apoptosis, alterations of surface markers and intracellular cytokine profile.
METHODS
We evaluated apoptosis formation by annexin V, CD25-related surface markers, and cytokine ratio of Th1/Th2 in CD4(+) T lymphocytes and Tc1/Tc2 in CD8(+) T lymphocytes of 42 ESRD patients haemodialysed with ERW for 1 year.
RESULTS
In comparison to 12 healthy individuals, the ESRD patients had more T-cell apoptosis and less CD3(+), CD4(+) and CD8(+) T cells and CD25/CD69/CD94/CD3(+) phenotypes at baseline. Lower intracellular IL-2 and IFN-gamma levels in the Th1/CD4(+) and Tc1/CD8(+) cells and higher intracellular IL-4, IL-6 and IL-10 levels in the Th2/CD4(+) and Tc2/CD8(+) cells were also noted in the ESRD patients. After a 1-year ERW treatment, the patients had a decrease in T-cell apoptosis and increases in CD3(+), CD4(+) and CD8(+) cell numbers and CD25/CD69/CD94/CD3(+) phenotypes in the T cells. The intracellular IL-2 and IFN-gamma levels in the Th1/Tc1 cells significantly (P < 0.05) increased and the intracellular IL-4, IL-6 and IL-10 levels in the Th2/Tc2 cells decreased. Furthermore, the Th1/Th2 and Tc1/Tc2 cytokine ratios were improved toward a normal status.
CONCLUSION
One-year ERW treatment effectively ameliorated T-cell apoptosis, altered CD25-related surface markers and intracellular cytokine profile in the HD patients.
背景
终末期肾病(ESRD)患者在接受慢性血液透析(HD)时,由于氧化应激增加导致 T 细胞损伤,从而导致 CD4+T 淋巴细胞凋亡增加,表面标志物改变以及 Th1/Th2 比例失衡。抗氧化电解还原水(ERW)被用作 ESRD 患者进行慢性 HD 的透析液,以测试改善与氧化应激相关的 T 细胞凋亡,改变表面标志物和细胞内细胞因子谱。
方法
我们评估了 42 名接受 ERW 血液透析治疗 1 年的 ESRD 患者的 CD4+T 淋巴细胞中 T 细胞凋亡的形成,通过 annexin V、CD25 相关表面标志物以及 Th1/Th2 细胞因子比值和 CD8+T 淋巴细胞中的 Tc1/Tc2。
结果
与 12 名健康个体相比,ESRD 患者在基线时具有更多的 T 细胞凋亡以及更少的 CD3+,CD4+和 CD8+T 细胞以及 CD25/CD69/CD94/CD3+表型。ESRD 患者的 Th1/CD4+和 Tc1/CD8+细胞中的细胞内 IL-2 和 IFN-γ水平较低,而 Th2/CD4+和 Tc2/CD8+细胞中的细胞内 IL-4,IL-6 和 IL-10 水平较高。在 ERW 治疗 1 年后,患者的 T 细胞凋亡减少,CD3+,CD4+和 CD8+细胞数量以及 T 细胞中的 CD25/CD69/CD94/CD3+表型增加。Th1/Tc1 细胞中的细胞内 IL-2 和 IFN-γ水平显著增加(P <0.05),而 Th2/Tc2 细胞中的细胞内 IL-4,IL-6 和 IL-10 水平降低。此外,Th1/Th2 和 Tc1/Tc2 细胞因子比值改善至正常状态。
结论
经过一年的 ERW 治疗,有效地改善了 HD 患者的 T 细胞凋亡,改变了 CD25 相关表面标志物和细胞内细胞因子谱。